Clinical Trial Update: Double-blind Study of Safety and Immunogenicity of Two Candidate Malaria Vaccines in Gabonese Children [Phase 2]

View source ↗

Summary

A Phase 2 double-blind study evaluated the safety and immunogenicity of two candidate malaria vaccines in Gabonese children; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Candidate malaria vaccine 1
• Candidate malaria vaccine 2

Snippet

Sponsor: GlaxoSmithKline | Conditions: Malaria | Phase 2 | Status: COMPLETED